[1] |
WANG Yaya, CHU Zixuan, YANG Junling, Olajide E. Olaleye, HE Rongrong, LI Muzi, CHENG Chen, LI Chuan.
Potential health benefits of resveratrol: a pharmacokinetics-caused conundrum
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 931-954.
|
[2] |
ZHAO Fangqing, YANG Wenwen, YIN Yujie, ZHANG Bin, WANG Bangcai, DOU Xiaobing, LI Songtao, ZHU Linwensi.
Salvianolic acid A activates AMPK and SIRT1 to reduce palmitic acid-induced lipotoxicity in hepatocyte
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 241-249.
|
[3] |
DENG Li, TIAN Jing.
Resveratrol suppresses NLRP3 inflammasome activation in colonic epithelial cells triggered by Escherichia coli O104∶H4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 167-173.
|
[4] |
WU Yi, ZHU Akao, SHAN Yuqiang, YING Rongchao, JIN Huicheng.
Resveratrol regulates miR-409-3p/FKBP14 to inhibit the malignant biological processes of gastric cancer BGC823 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 968-975.
|
[5] |
YUAN Lijialong, YUAN Ronghui, WANG Jin, DENG Ziwei, WANG Hongqiang, DENG Ye, GONG Lu, JIN Yuanxiang, SHI Zhihua.
Effects of resveratrol on autophagy of tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1066-1073.
|
[6] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[7] |
ZHOU Haiyan, WANG Kailing .
Resveratrol protects human retinal pigment epithelial cells from toxicity of high glucose by up-regulation of miR-26a
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 285-292.
|
[8] |
PAN Yalan, YUAN Wenchao, MA Yong, GUO Yang, ZHENG Suyang, XU Guihua, LIU Jiahuan.
Effect of JiSuiKang on the microglia infiltration and neuron survival in the spinal cord injury area of rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 151-158.
|
[9] |
SONG Hui, WANG Yinghao.
Resveratrol inhibits the proliferation of retinoblastoma cells via miR-937/FOXQ1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 174-181.
|
[10] |
LU Yubao, CHEN Yutong, HE Gege, CAI Zongyan, CHENG Yue, CHENG Zihua, GUO Jiamin, GUO Yanzhi.
Application of traditional Chinese medicine extract in repairing spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1075-1080.
|
[11] |
LIU Yadong, LU Xiaowei, LIU Zhigang.
Effects of EPO on serum calcitonin gene-related peptide in patients with acute spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 933-937.
|
[12] |
ZHANG Peng, CHEN Yongzhong, WANG Jinxing, ZHANG Jinfeng, WENG Chaoqun, YE Zhongxing.
Effect of ambroxol hydrochloride combined with high-dose methylprednisolone therapy on the recovery of neurological function after spinal cord injury in patients with thoracolumbar fractures
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 937-942.
|
[13] |
YU Qinyun, SU Xiaogong, BAO Qiying, CHEN Xiaoyan.
Effect of resveratrol on the Wnt/β-Catenin pathway in ovariectomized osteoporosis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 645-649.
|
[14] |
SONG Juan, TIAN Xiaoxia, LI Baohong, WANG Dong, MENG Dongchao, LU Yanzhen.
Effect and mechanism of resveratrol alleviates hepatic ischemia reperfusion injury by HMGB1 in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1215-1220.
|
[15] |
ZHANG Si, GU Bing, LI Hua-nan, WANG Shuo-yu, ZHANG Shui-yin.
Effect of methotrexate on spinal cord contusion-induced protein related with oxidative damage in rats at acute stage
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 1-6.
|